Paul L. Berns - Title: Chief Executive Officer and Chairman of the Board, Director at Neumora Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Title: Chief Executive Officer and Chairman of the Board, Director
Stock Symbol
NMRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Paul L. Berns - trading volume in the past year for Neumora Therapeutics, Inc.

Holdings reported by Paul L. Berns for Neumora Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7.41M $12.5M $1.69 Feb 18, 2025 Direct
Common Stock 133K $225K $1.69 Feb 18, 2025 Indirect
Stock Option (Right to Buy) 343K Feb 13, 2025 Direct Common Stock

Transactions reported by Paul L. Berns for Neumora Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.